News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,054 Results
Type
Article (34226)
Company Profile (343)
Press Release (681474)
Multimedia
Podcasts (134)
Webinars (22)
Section
Business (231797)
Career Advice (1225)
Deals (34810)
Drug Delivery (90)
Drug Development (79878)
Employer Resources (117)
FDA (15552)
Job Trends (13706)
News (338421)
Policy (28123)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (5)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (6)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2347)
Accelerated approval (50)
ADA (48)
Adcomms (18)
Allergies (184)
Alliances (50640)
ALS (236)
Alzheimer's disease (1833)
Antibody-drug conjugate (ADC) (556)
Approvals (16145)
Artificial intelligence (793)
ASCO (312)
Autoimmune disease (382)
Automation (62)
Bankruptcy (321)
Best Places to Work (11029)
BIO (77)
BIOSECURE Act (14)
Biosimilars (223)
BioSpace Insights (109)
Biotechnology (237)
Bladder cancer (194)
Brain cancer (74)
Breast cancer (818)
Cancer (6484)
Cardiovascular disease (519)
Career advice (1056)
Career pathing (39)
CAR-T (369)
CDC (43)
Celiac Disease (2)
Cell therapy (1019)
Cervical cancer (54)
Clinical research (70705)
Collaboration (2458)
Commercialization (7)
Company closure (3)
Compensation (1567)
Complete response letters (89)
COVID-19 (2048)
CRISPR (131)
C-suite (1417)
Cystic fibrosis (167)
Data (8958)
Decentralized trials (1)
Denatured (30)
Depression (194)
Dermatology (105)
Diabetes (633)
Diagnostics (6849)
Digital health (67)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (405)
Drug pricing (129)
Drug shortages (16)
Duchenne muscular dystrophy (341)
Earnings (89756)
Editorial (64)
Employer branding (13)
Employer resources (107)
Events (122272)
Executive appointments (1259)
FDA (19712)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (36)
Funding (1985)
Gene editing (278)
Generative AI (67)
Gene therapy (814)
GLP-1 (954)
Government (3061)
Grass and pollen (6)
Guidances (401)
Healthcare (17995)
Hematology (174)
HIV (89)
Huntington's disease (65)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (121)
Immunology and inflammation (321)
Immuno-oncology (114)
Indications (231)
Infectious disease (2391)
Inflammatory bowel disease (229)
Inflation Reduction Act (15)
Influenza (132)
Intellectual property (336)
Interviews (194)
IPO (16130)
IRA (26)
Job creations (3054)
Job search strategy (892)
JPM (56)
Kidney cancer (21)
Labor market (69)
Layoffs (437)
Leadership (52)
Legal (6783)
Licensing (10)
Liver cancer (94)
Longevity (33)
Lung cancer (851)
Lymphoma (467)
Machine learning (63)
Management (42)
Manufacturing (1123)
Marketing (13)
MASH (212)
Medical affairs (1)
Medical device (13307)
Medtech (13523)
Mergers & acquisitions (20084)
Metabolic disorders (1569)
mRNA (224)
Multiple sclerosis (200)
NASH (20)
Neurodegenerative disease (498)
Neuropsychiatric disorders (112)
Neuroscience (3581)
Neurotech (1)
NextGen: Class of 2026 (6264)
Non-profit (4049)
Now hiring (61)
Obesity (678)
Opinion (279)
Ovarian cancer (246)
Pain (274)
Pancreatic cancer (362)
Parkinson's disease (417)
Partnered (32)
Patents (647)
Patient recruitment (864)
Peanut (65)
People (61400)
Pharmaceutical (59)
Pharmacy benefit managers (19)
Phase 1 (22627)
Phase 2 (31441)
Phase 3 (22424)
Pipeline (10814)
Policy (244)
Postmarket research (2337)
Preclinical (9733)
Press Release (71)
Prostate cancer (349)
Psychedelics (79)
Radiopharmaceuticals (378)
Rare diseases (1283)
Real estate (5555)
Recruiting (48)
Regulatory (24024)
Reports (35)
Research institute (2364)
Resumes & cover letters (169)
Rett syndrome (48)
RNA editing (32)
RSV (74)
Schizophrenia (188)
Series A (350)
Series B (256)
Service/supplier (6)
Sickle cell disease (126)
Special edition (24)
Spinal muscular atrophy (172)
Sponsored (39)
Startups (3645)
State (2)
Stomach cancer (14)
Supply chain (113)
Tariffs (54)
The Weekly (100)
Vaccines (889)
Venture capital (129)
Weight loss (402)
Women's health (132)
Worklife (17)
Date
Today (124)
Last 7 days (744)
Last 30 days (2485)
Last 365 days (30714)
2026 (19209)
2025 (30042)
2024 (34980)
2023 (39709)
2022 (49995)
2021 (54151)
2020 (51572)
2019 (43884)
2018 (32925)
2017 (30922)
2016 (29947)
2015 (36462)
2014 (30718)
2013 (25919)
2012 (27933)
2011 (28225)
2010 (26733)
Location
Africa (575)
Alabama (103)
Alaska (6)
Arizona (393)
Arkansas (14)
Asia (38994)
Australia (6445)
California (14677)
Canada (4070)
China (1581)
Colorado (627)
Connecticut (603)
Delaware (419)
Europe (84338)
Florida (2215)
Georgia (478)
Hawaii (4)
Idaho (63)
Illinois (1170)
India (108)
Indiana (567)
Iowa (24)
Japan (630)
Kansas (138)
Kentucky (54)
Louisiana (59)
Maine (48)
Maryland (1682)
Massachusetts (10711)
Michigan (406)
Minnesota (758)
Mississippi (7)
Missouri (168)
Montana (37)
Nebraska (24)
Nevada (161)
New Hampshire (87)
New Jersey (3812)
New Mexico (35)
New York (3856)
North Carolina (1893)
North Dakota (11)
Northern California (7465)
Ohio (443)
Oklahoma (25)
Oregon (41)
Pennsylvania (2898)
Puerto Rico (29)
Rhode Island (51)
South America (954)
South Carolina (92)
South Dakota (2)
Southern California (5831)
Tennessee (242)
Texas (2420)
United States (51754)
Utah (443)
Vermont (2)
Virginia (323)
Washington D.C. (68)
Washington State (1217)
West Virginia (4)
Wisconsin (163)
Wyoming (1)
716,054 Results for "lead therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Bespoke gene-editing outfit abandons lead program, cuts ‘several’ employees
Seven months after launching with $16 million in seed financing, Jennifer Doudna’s Aurora Therapeutics is pivoting away from its lead indication, phenylketonuria, owing to growing competition in the field.
August 5, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™
June 30, 2026
·
3 min read
Press Releases
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
August 10, 2026
·
10 min read
Press Releases
ReCode Therapeutics Announces New Funding from the Cystic Fibrosis Foundation, Collaboration with a Leading Gene Editing Company and Leadership Transition
August 6, 2026
·
5 min read
Press Releases
Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802
June 22, 2026
·
2 min read
IN PARTNERSHIP WITH ARVINAS
Life after the lead asset: Advancing an early-stage pipeline
In this episode of Denatured presented by Arvinas, Jennifer Smith-Parker speaks to Arvinas President and CEO Randy Teel about the strategic discipline and leadership required to successfully refocus a company on an early-stage pipeline after a lead asset is outlicensed, discontinued or otherwise falls away.
July 30, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Press Releases
Corrixr Therapeutics Names New CEO to Accelerate Momentum in Lead Program
June 3, 2026
·
3 min read
Press Releases
Protagenic Therapeutics’ Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model
June 30, 2026
·
4 min read
Press Releases
Telum Therapeutics Secures €18 Million Series A Financing to Advance Lead Antimicrobial Program into Clinical Development
July 1, 2026
·
1 min read
Press Releases
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
June 1, 2026
·
7 min read
1 of 71,606
Next
